glp-1alzheimers-riskneurodegeneration
GLP-1 Drugs and Brain Health: Can They Reduce Alzheimer’s Risk?
Preclinical and early clinical data suggest GLP-1 receptor agonists modulate pathways implicated in Alzheimer’s disease; this review synthesizes mechanisms, animal and human evidence, pharmacology, and gaps for translational research.
April 21, 2026
